Cytodyn Inc (CYDY)

[gestalt2]

I agree Axe, The risk of the R/S and uplist must be weighed against staying on the OTC. The past few PR's have clearly shown how the OTC has kept the SP from moving up as it should have. The SP was in high risk mode last year, now that the combo trial has such positive PE results the risk is far less and the SP is the same. We all anticipated a big jump in the SP as a result of getting the PE results and we now see how much the OTC sucks. I really am getting tired of the financial manipulations from mgmt but it looks to me there is no point in thinking the SP will move to a level that matches the potential of pro 140 if we stay on the OTC. Fear of what might happen after the R/S and uplist is real but necessary. There a plenty of past examples of uplists that worked, we discussed the differences before. Just because the history shows that R/S tactics are generally show a lot of downward pressure and shorting, most companies that turn to a R/S are in a bad situation already. This is a very different situation and this is not an attempt to prolong a failure, it is to fix a problem which is the OTC.

I was hoping that possibly the R/S and uplist was ditched because of some pending deal and the uplist would be not needed but it looks like the deal we are hoping for is still far off. We can't do much about that. I also think a big part of the future uplist is to get far greater liquidity for large share holders. Investing heavily in a company requires the ability to get out of the investment and the OTC volume is just too small. I see post uplist that we see far better liquidity and bigger blocks of buyers stepping in.